Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial - CORRIGENDUM.

Authors :: Loo C
Glozier N
Barton D
Baune BT
Mills NT
Fitzgerald P
Glue P
Sarma S
Galvez-Ortiz V
Hadzi-Pavlovic D
Alonzo A
Dong V
Martin D
Nikolin S
Mitchell PB
Berk M
Carter G
Hackett M
Leyden J
Hood S
Somogyi AA
Lapidus K
Stratton E
Gainsford K
Garg D
Thornton NLR
Fourrier C
Richardson K
Rozakis D
Scaria A
Mihalopoulos C
Chatterton ML
McDonald WM
Boyce P
Holtzheimer PE
Kozel FA
Riva-Posse P
Rodgers A
Source :: The British journal of psychiatry : the journal of mental science [Br J Psychiatry] 2024 Aug; Vol. 225 (2), pp. 349. Date of Electronic Publication: 2024 Oct 14.
Publication Year :: 2024

Language :: English
ISSN :: 1472-1465
Volume :: 225
Issue :: 2
Database :: MEDLINE
Journal :: The British journal of psychiatry : the journal of mental science
Publication Type :: Editorial & Opinion
Accession number :: 39399907
Full Text :: https://doi.org/10.1192/bjp.2024.189

Full Text Access

Tools